Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02340663Not ApplicableCompleted

Nocturnal Mouth Guards, SOVA vs. Standard Acrylic Orthotic; Phase IV

Role: collaborator

NCT01629290Not ApplicableCompleted

In Vivo Comparison of Salivary Fluoride Levels Following the Application of Different 5% NaF Varnishes

Role: collaborator

NCT00103493Phase 3Completed

Oral Health Education Program

Role: collaborator

All 3 trials loaded